SHL Telemedicine Ltd.
SHLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.00 | 28.09 | 0.00 |
| FCF Yield | -9.29% | -6.73% | -3.29% | -1.50% |
| EV / EBITDA | -2.86 | 38.61 | 24.82 | -30.73 |
| Quality | ||||
| ROIC | -45.76% | -8.99% | -0.87% | -0.43% |
| Gross Margin | 45.43% | 44.26% | 46.08% | 49.60% |
| Cash Conversion Ratio | 0.01 | 0.21 | -0.34 | -0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.27% | 4.80% | 13.68% | 5.79% |
| Free Cash Flow Growth | 42.09% | 0.10% | -127.04% | -205.60% |
| Safety | ||||
| Net Debt / EBITDA | -0.46 | 4.35 | 2.35 | -2.43 |
| Interest Coverage | -23.88 | -5.77 | -4.01 | -0.59 |
| Efficiency | ||||
| Inventory Turnover | 26.46 | 9.20 | 8.20 | 5.95 |
| Cash Conversion Cycle | 19.60 | 55.68 | 58.23 | 85.57 |